Table 4.
Summarization of All the Adverse Events
| Non-Elderly Group (N=10) | Elderly Group (N=9) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Incidence (%) | Severity Grade | Incidence (%) | Severity Grade | ||||||
| I | II | III | I | II | III | ||||
| All adverse events | 2(20.0%) | 2 | 0 | 0 | 2(22.2%) | 2 | 0 | 0 | |
| Acute upper respiratory infection | 1(10.0%) | 1 | 0 | 0 | 0(0.0%) | 0 | 0 | 0 | |
| White blood cell increased | 1(10.0%) | 1 | 0 | 0 | 0(0.0%) | 0 | 0 | 0 | |
| Aspartate transaminase increased | 0(0.0%) | 0 | 0 | 0 | 1(11.1%) | 1 | 0 | 0 | |
| Blood bilirubin increased | 0(0.0%) | 0 | 0 | 0 | 1(11.1%) | 1 | 0 | 0 | |
| Blood glucose increased | 1(10.0%) | 1 | 0 | 0 | 0(0.0%) | 0 | 0 | 0 | |
| Fibrinogen decreased | 1(10.0%) | 1 | 0 | 0 | 0(0.0%) | 0 | 0 | 0 | |